Corpus Intelligence IC Memo — PROVIDENCE SEASIDE HOSPITAL 2026-04-26 11:19 UTC
IC Memo — PROVIDENCE SEASIDE HOSPITAL
Investment Committee Memorandum | OR | 33 beds | Grade C | EBITDA uplift $5.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PROVIDENCE SEASIDE HOSPITAL

CCN 381303 | CLATSOP, OR | 33 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PROVIDENCE SEASIDE HOSPITAL is a 33-bed rural/critical access in CLATSOP, OR with $80.5M in net patient revenue and a -17.8% operating margin. The hospital serves a payer mix of 57.7% Medicare, 2.6% Medicaid, and 39.6% commercial.

Thesis: Turnaround. Our ML models identify $5.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -17.8% to -10.4% (+736bps).

Net Revenue HCRIS$80.5M
Current EBITDA COMPUTED$-14.3M
Operating Margin COMPUTED-17.8%
Occupancy HCRIS40.0%
Revenue / Bed COMPUTED$2.4M
Net-to-Gross HCRIS47.3%
Distress Probability ML51.2%

2. Market Context & Competitive Position

63
OR Hospitals
-8.1%
State Median Margin
28
Comparable Hospitals

OR has 63 Medicare-certified hospitals with a median operating margin of -8.1%. The target's margin of -17.8% places it below the state median. Among 28 size-comparable peers (16-66 beds), the median margin is -5.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (16-66), prioritizing same-state peers. 28 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PROVIDENCE SEASIDE HOSPITAL (Target)OR33$80.5M-17.8%
GOOD SHEPHERD MEDICAL CENTEROR25$177.5M5.3%
COLUMBIA MEMORIAL HOSPITALOR25$165.9M5.2%
SAMARITAN LEBANON COMM HOSPITAOR25$157.9M3.9%
PROVIDENCE NEWBERG MEDICAL CENOR40$151.5M10.0%
SAMARITAN PACIFIC COMM HOSPITAOR25$141.7M3.7%
GRANDE RONDE HOSPITALOR25$134.8M-4.1%
PROVIDENCE MILWAUKIE HOSPITALOR40$128.8M-9.6%
MID-COLUMBIA MEDICAL CENTEROR44$123.2M-20.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.7M+210bp18mo
Cost to Collect4.5%2.5%$1.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$979K+122bp9mo
Clean Claim Rate88.0%96.0%$52K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.7M
Cost to Collect
$1.6M
Denial Rate Reduction
$1.6M
A/R Days Reduction
$979K
Clean Claim Rate
$52K
Total EBITDA Uplift$5.9M
Current EBITDA$-14.3M
+ RCM Uplift+$5.9M
Pro Forma EBITDA$-8.4M
Current Margin-17.8%
Pro Forma Margin-10.4%
WC Released (1x)$3.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-22.0M$-35.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-22.0M$-45.9M0.00x-100.0%
Bull Case9.0x11.0x$-19.8M$-33.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-19.8M$-42.4M0.00x-100.0%
Bear Case11.0x10.0x$-24.2M$-57.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-24.2M$-71.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 57.7% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
HighElevated distress probabilityModel estimates 51.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 28 hospitals with 16-66 beds
  • Same-state prioritization (n=29)
  • Comp margins: P25=-14.4% / P50=-5.8% / P75=3.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.